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Summary
We studied the 5' untranslated regions (UTRs) of the mouse lymphocyte pore-forming protein
(PFP, perforin, and cytolysin). 5' UTRs were determined by primer extension analysis, sequencing
PFP cDNA clone PFR7, ribonuclease protection assays, and amplification of poly(A)+ RNA
of cytolytic T lymphocyte using polymerase chain reaction (PCR). Two alternatively spliced
5' UTRs, designated type I and type II, of 222 and 115 bp, respectively, were found associated
with PFP. Type II is identical to type 1, except for being 107 by shorter in the second exon.
This deletion was generated.by the use of alternative acceptor splice sites. The mouse PFP gene
(Pfp) encodes three exons, is separated by two small introns, and spans a chromosomal region
of N7 kb. The first exon contains 79 by of 5' UTR, the second exon contains 143 or 36 by
of 5' UTR (type I or type II UTR, respectively) plus the NHz-terminal region of the mouse
PFP, and the third exon contains the rest of the COOH-terminal mouse PFP. The organization
of the mouse Pfp is similar to that of the human gene. Moreover, the 5' flanking sequence of
the mouse Pfp is highly homologous to that of the humanPfp. In contrast to the human sequence,
the more immediate 5' flanking sequence of mousePfp contains two tandem "TATA"box-related
elements and a GC box, but lacks a typical CAAT box-related sequence. Several other enhancer
elements were found further upstream, including CAMP-, phorbol ester-, interferon-y-, and
UVresponsive elements, and PU box-like and NFkB binding site-like elements. In addition,
we found a nuclear inhibitory protein-like element, a transcriptional silencer, and a pair of purine-rich
sequence motifs that were found in other T cell-specific genes, and three repeats of GGCCTG
that may be a variation of a highly repetitious GCCCTG consensus sequence found in human Pfp.
T
he lymphocyte pore-forming protein (PFP;t also termed
perforin or cytolysin)is the only cytolytic mediator known
to be produced exclusively by CTL and NK cells (1-5). Both
human and mouse forms of PFP have been cloned (6-9), and
their expression has been found to be regulated by various
lymphokines and mitogens known to activate cytolytic lym-
phocytes (10-14). Recently, the genomic organization ofboth
the human (15) and the mouse (16) genes encoding PFP (desig-
nated as Pfp) was partially elucidated.
In the case of the mouse Pfp, the 5' region has yet to be
sequenced. The incomplete gene structure for mouse Pfp
reported earlier (16) was derived by comparing genomic se-
'Abbreviations used in this paper. AP, activator protein; CRE, cAMP-
responsive element; NIP, nuclear inhibitory protein; PFP, pore-forming
protein; TPA, 12-O-tetradecanoylphorbol-13-acetate; TRE, TPA-responsive
element; UTR, untranslated region.
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quences with the PFP sequences provided by two overlap-
ping cDNA clones, designated PFR6 and PFP-15. PFP-6 cov-
ered most of exons 2 and 3, whereas PFP-15 contained the
more 5' end sequence, including part of exon 1. Subsequent
studies showed that although PFP-15 overlapped with PFP-6
in the coding region, its 5' untranslated region (UTR) was
encoded by a different genomic clone, XPFR67, which was
found not to overlap with clone XPFP-64 studied here. While
the protein coding region of Pfp maps to chromosome 10,
the 5' UTR of PFP-15 was found .to map to chromosome
7 (our unpublished observation), indicating that the regula-
tion of the PFP-15-like transcript, if authentic, would have
to be done in transchromosomal fashion, an event without
precedence in the mammalian system. The PFR15-like 5' UTR
was also found to be very rare, based on primer extension
analysis and PCR amplification ofCTLL mRNA usingPFP-
J. Exp. Med. ® The Rockefeller University Press " 0022-1007/91/04/0813/10 $2.00
Volume 173 April 1991 813-82215-specific forwardand reverse primers. Finally, several puta-
tive exon-intronjunction sequences for PFP-15-like 5' UTR
do notfit favorably to the splicing consensus. Taken together,
the 5' UTR contained in PFP-15 does not appear to be
authentic or may represent a minor species.
Since the cis-acting regulatory elements located at the 5'
flanking region are likely to respond to the various signals
known to induce the expression of Pfp, we sought to deter-
mine the transcription initiation site and 5' flanking region
of mousePfp with the objectiveof analyzing potential tran-
scription regulatory sequences. To define the transcription
initiation site for Pfp, the 5' UTR of mouse PFP mRNA
was first determined. This led to the surprising finding that
two main 5' UTRs are associated with PFP, which aregener-
ated by an alternative splicing. We report the structures of
these 5' UTRs and analyze the 5' flanking sequences of Pfp
with respect to putative promoter and enhancer regions.
Materials and Methods
Cells.
￿
Murine CTL lines CTLLR8 and CTLLA11 (17) were
grown in DMEM with 5% FCS and 4 U/ml of human rID2
(Boehringer Mannheim Biochemicals, Indianapolis, IN). A mu-
rine thymoma line, E1,4, was maintained in the same medium as
abovewithout 11,2. Murine melanoma Cloudman S-91 cellswere
grown in Ham'sF-10 medium with 8% Nu-serum (Collaborative
Research, Boston, MA) (18).
Ikrforin cDNA andGenomic Clones.
￿
Perforin cDNA clones were
isolated from a hgt11 cDNA libraryconstructed from the murine
CTLline CTLILA11 as describedpreviously (8). Themousegenomic
clones XPFP-64 and XPFP-67 were described previously (16). The
two genomicclones do not overlap each other; XPFP-64 contains
the entire coding region of themouseperforin gene, andXPFP-67
contains part of the 5' UTR of a cDNA clone called PFP-15.
DNA Sequencing. The nucleotide sequences of cDNAs or
genomic fragments were determined by the dideoxy chain termi-
nation method (19, 20) using Sequenase (United States Biochem-
ical Corp., Cleveland, OH). Thegenomicor cDNA fragmentswere
either subclonedin M13 vectors (21) foruse as single-stranded tem-
plates or subcloned in pGEM vectors (Promega Biotec, Madison,
WI)foruseas deleted double-stranded templates(22),whichwere
generatedby exonuclease III-mediated deletion (Promega Biotec).
PCR ofmRNA.
￿
Thefirst-strand cDNA wassynthesized from
poly(A)' mRNA of CTLIrAll, EL4 cells, or Cloudman S-91
cells usingrandom primer by avianmyoblastosis virusreverse tran-
scriptase (Life Sciences, St. Petersburg, FL). The cDNA RNA
hybridswere then amplified into double-stranded cDNA by PCR
(23) using sets of forward andreverse primers as describedbelow.
ThePCRreaction consistedof denaturation at 95°C for 0.5 min,
annealing at 55'C for 1.5 min, and extension at 75'C for2 min.
The PCR product was analyzed either by direct sequencing, blot
hybridization, or cloning and sequencing.
Oligonucleotides.
￿
The positionsofeach oligomer were indicated
in Fig. 1. Oligomer 1:areverseprimer complementary to 5'-GTG-
GCGTCTTGGTGGGAC-3': This 18-mer represents the5' end of
5' UTRof thecDNA PFP-7. Oligomer 2: areverse primer com-
plementary to 5'-GACTACTGTGCCTGCAGCATC-3'. This 21-
mer is from 5' UTR of PFP-7 and adjoins the intiation codon.
Oligomer 3: a forward primer 5'-GGAATTCAGAT000AGC-
ATTTTAAA3'.This 25-mer represents the 5' endofthefirst exon
of PFP gene. This oligomer contains 18 nucleotides of 5' UTR
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sequence and seven extra nucleotides of EcokI cloning site. Oli-
gomer 4: a 15-mer 5'-GCATCCTTCATCCCT3' that is unique
to type 15' UTR.
Primer Extension Analysis. 2 P.g of poly(A)' RNA from
CTLLR8, CTL1,A11, or melanoma Cloudman S-91 cellswere an-
nealed with 5pmol ofkinased oligonucleotideprimer at 30°C over-
night in a buffer containing 0.4 M NaCl, 40 mM Pipes, pH 7.0,
1.0 mM EDTA, pH 8.0, and 80% formamide. The mixture was
ethanol precipitated andresuspended in a buffer containing 50 mM
Tris HCl (pH 7.6), 60 mM KCI, 10 MM M9Clz, 1.0 mM DTT,
1.0 mM each dATP, dGTP, dCTP, dTTP, 1,000 U/ml RNAsin
(Promega Biotec), and 20 U of AMV reverse transcriptase (Life
Sciences). The mixture was incubated at 37°C for 2 h, extracted
with phenol-chloroform, andprecipitated with ethanol. Theprecipi-
tate was resuspended in 10 mM Tris-HCI (pH7.4), 10 mM EDTA,
incubatedwith 50 ug/ml RNAseAat 37°C for30 min. The reac-
tion product was analyzed by sequencing gel.
OligomerHybridization.
￿
DNAblots of PCRproducts or cloned
genomic fragments were prepared by electrophoresis onto Gene
Screen plus (New EnglandNuclear, Boston, MA), followed by hy-
bridization to oligomers at 37-42'C (depending upon the size of
the oligomer) in 6x SSC, lx Denhardt, 0.5% SDS, 0.05%
pyrophosphate, and 100 Wg/mlsalmon spermDNA. Theblot was
washed at room temperature twicefor 10 min each andat hybrid-
ization temperature for 4 min once.
Ribonuclease Protection Assay.
￿
To generate a suitable RNAprobe,
we first amplifieda2.4-kbfragment that spannedfrom the RNA
startsite to the nucleotide next to theinitiation ATG codon(from
oligomer 3 to oligomer 2). The amplified fragment was digested
with Ncil, which generates a0.35-kb 3' end fragment. The frag-
ment wasblunt-ended by Klenow fragmentsofEscherichia coli DNA
polymerase I. Theresulting fragment wasdigested withPstI,which
is located at the 3' endof this fragment and cloned into SmaI and
Pstl sitesofpGEM 3cloningvector (Promega Biotec). Therecom-
binant plasmid waslinearized by EcoRI digestion andused for in
vitrotranscription. In vitro transcription wasperformedin thepres-
ence of ac-[31P]CTP andSP6 polymerase to produce the antisense
RNA probe as described in the Riboprobe Gemini Transcription
System (Promega Biotec). After digestion of the template DNA
and RNAfree DNase I (RQ DNase I; Promega Biotec), the la-
beled RNAwasethanol precipitated anddissolvedin RNAloading
buffer containing 80% formamide. The RNA was denaturedby
heating for 5 min at 85°C, quickly chilledon ice, and then loaded
on a3.5% nondenaturing polyacrylamide gel. The gel was disas-
sembled and exposed to film for 30 s. The full-length RNA band
was excised, crushed, and eluted in 400 Etldiethyl pyrocarbonate-
treated 0.1 x SSCfor 2 h. The labeled RNAwasethanolprecipi-
tatedanddissolvedin 50 pl hybridization buffer (80% formamide,
40 mM Pipes [pH 6.4], 400 mM NaCl, and 1 mM EDTA).
Two sets of CTLLR8 RNAandyeasttRNA were vacuum dried
and dissolved in 30 1Al hybridization buffer containing 5 x 10,
cpmofthelabeled RNA. Afterbeingoverlayedby 30 Al ofmineral
oil, one set of RNAs was hybridized at 45°C, and the other set
was hybridized at 50°C for 12 h. The 350-,ul ribonuclease diges-
tion buffer (10 mM Tris-Cl [pH 7.5], 300mM NaCl, and 5 mM
EDTA), including 40 ug/ml ribonuclease A and 2 p.g/ml
ribonuclease Tl,wasaddedto thehybridized RNAs andincubated
1 h at 30°C. After theribonuclease digestion, 20 Pl of 10% SDS
and 2.5 Al of 20 mg/ml proteinase K were added and incubated
15 min at 37°C. Then the reaction mixture was extracted with
phenol and recovered by ethanol precipitation. The RNA pellet
wasdissolvedin 10 plRNAloadingbuffer anddenaturedfor3 min
at 85°C, and 5 td was loaded on 6% sequencing gel. M13mp18DNA was sequenced by the Sequenase and run in parallel with
the above ribonuclease-protected fragments for size estimation .
Results
5' UTR ofPFP-7, Transcription Initiation Site, and Exon-Intron
Boundaries. A previous study on mousePfp revealed the pres-
ence of three exons, only two of which encode polypeptide
(16) . The 5' UTR sequence of PFP transcript remains in-
complete, as the transcription initiation site was not deter-
mined in that study (16) . In the present study, the nucleo-
tide sequence of a 2.5-kb cDNA clone containing 5' UTR,
designated PFP-7, was determined . PFP-7 contained 166 by
of 5' UTR sequence (Fig . 1 A) .
To determine the transcription initiation site ofPfp, primer
extension analysis was performed using poly(A)+ RNA
from mouse CTL lines CTLLR8 and CTLLAII . An 18-mer
oligonucleotide probe (designated oligomer 1 ; see Fig. 1 A)
corresponding to the most 5' end of the PFP-7 was used as
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￿
Nucleotide sequence of two types of 5' UTR of the mouse
perforin transcripts . (A) Nucleotide sequence of5'UTR ofcDNA PFP-7.
The cDNA, cloned initially in Xgt11, was subcloned into the EcoRl site
of M13mp8 . The nucleotide sequence was determined using an universal
primer. (B and C) The complete nucleotide sequences of types I(B) and
II(C) 5' UTR of the mouse Pfp . Restriction enzyme sites are indicated
by the overline and the names of each enzyme . The nucleotide sequence
of each oligomer used in this study is underlined with a 5' - 3' arrow.
The nucleotide sequences corresponding to exon I were boxed . Only 23
nucleotides of exon I were cloned in PFP-7 cDNA . The 36 nucleotides
of exon II common to types I and II were underlined with a thick line.
The numbers over the nucleotides indicate the nucleotide position ofeach
5'UTR sequence (mRNA start siteas +1) . The sequence of 107by unique
to type I 5' UTR can be recognized between the 3' end of the box and
the 5' end of the thick line (A and B) .
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primer for extension experiments. There was one major
product of 74 by extending to the cap site (a total of 56 by
extending beyond the 18-bp sequence) (Fig. 2) . This result
could be reproduced in separate experiments using poly(A)+
Figure2 .
￿
Primer extension analysis for determination ofcap site oftypes
I and II Pfp 5' UTR . An 18-mer oligonucleotide (oligomer 1) starting
at five bases away from the 3' end of the first exon was used both as a
primer for reverse transcriptase to primecDNA synthesis and for sequencing
the 2.4-kb EcoRI fragment containing the 5' end ofPfp . The nucleotide
sequence ladder on the left represents the sequence surrounding the cap
site. The arrow with +1 indicates the cap site residue A . The ATrich
region (potential TATA element) between positions -43 and -32 is indi-
cated with arrows and numbers. The thick arrow at the right side indi-
cates the primer extension product (74 bp) . Thus, with the five bases at
the 3' end, the complete first exon constitutes 79 bp. The M13 sequence
was used to determine the length of the extension product (not shown) .
R8 and All indicate the CTL cell lines CTLI.R8 and CTL1,All, respec-
tively. The amount of RNA for the extension was 2 wg poly(A) " for
CTLI,R8 and for CTLLAll .RNA from both CTLLR8 and CTLIrAII, but not from
control EL-4 or Cloudman S-91 cells.
The same oligomer 1 was used to probe an EcoRI-digested
APFP-64DNA blot . APFP-64, a genomic clone with an in-
sert of-18 kb, was previouslyshown to contain all the coding
region of Pfp plus N11 kb of 5' flanking region . Oligomer
1 hybridized to the 2.4-kb EcoRI fragment . We constructed
a partial restriction map for APFP-64 and determined the
nucleotide sequence of the entire 2.4-kb EcoRI fragment .
As shown in the restriction map of the APFP-64 insert (Fig.
3), the first exon contains 79by and is separated by a N1.9-
kb intron from the second exon . The 18 by represented in
oligomer 1 plus 5 by downstream constitute the 3' end of
the first exon . Exon 2 contains part of the protein coding
region ofPFP (as described earlier in reference 16) plus 143
by of 5' UTR extending beyond the ATG codon .
Two Main Types of5' UTR ofMousePFPmRNA Are Gener-
ated by an Alternative Splicing. To further examine whether
the UTR sequence derived from PFP-7 belongs de facto to
mouse PFP mRNA, we designed the following reverse and
forward primers to amplify the 5'UTR byPCR. Oligomer
2 is a reverse 21-mer primer corresponding to the sequence
immediately upstream of the ATG codon (Fig. 1) . Oligomer
3 is a forward 25-mer primer with 7 by matching the EcoRI
cloning site plus 18 by corresponding to the most 5' end of
the exon 1, the latter sequence being derived from the primer
extension analysis (Figs. 1B and 2) . If the 5'UTR sequence
of PFP-7 and that determined from the primer extension se-
Figure 4 .
￿
PCR-amplified products as-
sociated with types I and 115' UTR of
the mouse Pfp . The primer set for PCR
amplification of the 5' UTR of Pfp con-
stitutes oligomers 2 and 3 . The PCR
products were fractionated on 2.0%
agarose gel and transferred to the Gene
Screen Plus membrane, and hybridizedto
oligomer 1 (lane 1) and oligomer 4 (lane
2) . Oligomer 4 is specific to type I 5'
UTR . Oligomer 1 detects both type 1
and type 11 5' UTR . The numbers indi-
cate the size in base pairs of each band.
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Figure 3 .
￿
Partial restriction map ofgenomic insert
of "FP-64 . This map is complete only for the indi-
cated restriction enzymes EcoRI and Sall (drawn to
scale) . The positions of the various exons in XPFP-64
are represented by boxes (not drawn to scale) . Note
1kb
￿
that only part of exon III is encoded by XPFP-64 .
quence are correct, then these two primers should generate
fragments of 222 by amplified from mRNA .
When we amplified the poly(A)+ RNA from CTLLR8,
we consistently found two bands, one with the expected size
of 222 bp, and another smaller band of 115 bp. When the
amplifiedDNA fromCTLLR8 was transferred to Gene Screen
Plus membranes and hybridized with oligomer 1, both bands
produced positive signals (Fig. 4, lane 1) . The smaller type,
which we refer to as type II, was -15-fold more abundant
than the larger one, or type I . We subcloned the smaller band
and determined its nucleotide sequence. As shown in Fig .
1 C, the type 11 5'UTR was formed by elimination of 107
by from type I 5' UTR in a region corresponding to the
most 5' end of exon 2 (see, also, the schematic diagram of
the two 5' UTRs in Fig . 6) . To further verify that the type
I 5' UTR contains this 107-bp sequence, oligomer 4 (Fig .
1 A and B), representing this region, was used to hybridize
the sameDNA blot described above . As shown in Fig. 4 (lane
2), oligomer 4 recognized the upper band only. We were able
to determine the sequence of the type 15' UTR only by di-
rect sequencing of thePCR product usingPCR and internal
primers (oligomers 1, 2, and 4) . We were not able to clone
the larger band despite numerous attempts, an observation
that may suggest that the larger 5'UTR may be an unstable
product, thus resulting in reduced cloning efficiency.
We ran controls for each component of the PCR to avoid
any false positives due to contamination with either cDNA
or genomic clones . The controls included separate tubes of
Cloudman S-91 cellmRNA with all the PCR mixture and
PCR reaction mixture withoutCTLLmRNA. Controls did
not produce any signal in all experiments tested.
To confirm our results on the alternative splicing, we used
a ribonuclease protection assay, using anRNA probe span-
ning thetwo alternative splicing acceptor sites. The antisense
RNA probe spans from the NciI site in the first intron to
the PstI site adjacent to the initiation ATG codon (Fig. 5 A) .
The NciI site locates at 0.35 kb upstream to the A residue
of the initiation ATG codon, while the PstI site locates at
four bases upstream to theATG codon. Type ImRNA should
produce 139 base-protected fragments, and type II mRNA
should produce 32 base-protected fragments (Fig . 5 A) . The
difference between the two protected fragments should be
107 bases. As shown in Fig. 5 B, CTLLR8mRNA yielded
thetwo protected fragments of the expected sizes. The differ-
ence in size between the two fragments was 107 bases .RNA
from mouse spleen and bone marrow cells also produced theD
￿
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®
￿
Coding Region
Protected Fragment
Nci I
RNA Probe
Pat I
Pat I
139 bases
II
ATG
32 bases
Figure 5 .
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Ribonuclease protection assay to show thealternative splicing
of PFPmRNA . (A) Schematic diagram of strategy and expected sizes of
protected fragments . Exons are indicatedby Roman numerals ofeach box .
ATG indicates the initiation codon . Enzyme sites are indicated by arrows .
The antisense RNA probe spanning from the Ncil site in the intron to
the Pstl site adjacent to the ATG condon was drawn with a thick line .
Expected sizes ofprotected fragments for type I and type IImRNA were
indicated . (B) Sequencing gel showing the ribonuclease-protected frag-
ments . At left, ACGT indicates the M13mp8 sequence ladder to estimate
the sizes ofprotected fragments. At right, theRNA probe was hybridized
to CTLIrR8 cell RNA at 50°C (lane 1) or at 45°C (lane 4) . YeasttRNA
was hybridized to CTLIjR8 cellRNA at 50°C (lane 2) or at 45°C (lane
3) as control. (I) The protected fragments of type I mRNA ; and (II) the
protected fragments of type 11 mRNA .mouse perfoNn gene
TYPEI mRNA
TYPE II mRNA
(major transcript)
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perforin gene
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1.2kb
GAAATGCGAA GTAAGTTTTA GTTAAGGTGA TGTATATCTC
ATATAGGAGA TA-AAAATGGA tAAATGAAGGC AGGTTTGGTG
T cell-specific
TGGTGATCTC GACAAGAATT GGACACTGAT TATAGTACTG
-1120 GGCAAGTGTG ATACCCTGAG CTACATCCCC AGGCTCCTCC CTCTGACTTC
CRE
-1040 TTAAAAAA&&_ AAGCTGTTAA AAGTGTGTTT CTGATGTAGC GGGACTGGAG
T cell-specific
GGCTTTTTGC AGGTTTCTGC AGCCTGTACC TTGTTCTTCC AGCATGGCTA
CAGTCAGACC AgCAGGCAG AGTGCCAACG TGGGGCCACA
r-INF
GTTCTGAGAA AGGTGGCACA AGCCCGGGTG GATGTGACCA TGTGGCCTGG
TCACTTAGGG GTGTTGAGAA CTACCCCCAC CCTGCATGGT TTTACCCACC
AP-2
CCCCAGTAGG TATCCATTOA GTCACTCTGC CCATGGAAAC
AP-1 NIP
CTTTCCACAG TACTAGCCTG CTCAAACCTG AGGTTCAGCT
GGGCAACTGC AGTTTCTGCA
CTCCCACAGT AACCTCAGGC
GGGATGTAGG TATGGACAGG
AP-2
1126
Figure 6 .
￿
Organization ofmouse Pfp and two types of transcripts, and comparison with human Pfp . Exons are shown as boxes : open box, 5'UTR;
stippled box, coding region; dotted box, 3' UTR. The 5' and 3' flanking sequences are shown as lines and intron sequences as disconnected lines. Exons
are indicated by Roman numerals above each box, and intron sizes are indicated. The numbers at the tip of each axon of the mouse perforin gene
represent the positions of nucleotide from themRNA start site. Numbers below each box oftype I and II transcripts and human perforin gene indicate
the length of each exon . The numbers at the third exon of the mouse and human Pfp indicate the size of the coding region only, not including the
length of the 3' UTR.
GAATTCT TAGGAAAGAT TCTACTCGTG GCCTAGAAAA ACTTAAGGCA TTGTTAGCAT TATATAATAA
-1760 GTTCTTTTTT TTTTTTAATA GTGAGATTTG GTTACTCTCT TGCAATGATT TCTTATAAAG TGGATCTTTA CTATGTAATA
-1680 CAAATACTCA CTATTTAAAG TATCTGGCAT CTCACATTAC TTATTTGTTA AATCCATGTA ACATTATCCT TAAAAATTAT
-1600 AATCTGGATA AGTTTCCAGT GGATATTTAG TGTTTCAATT AAAAGCAAAT CAGTTTTAAT ATTTCAAGTT TTCTTCATTG
-1520 AAGCTGGTAA CATTGCTAAG AATATAGTAT GGAGTAAAAC TTTTTATTAG CAGTGAGAAA AAAATATGTT TAATTCTCAA
-1440 ATACTATAAA ATTATTTAGA GTTACAATCC CCAACATTTC CTTCAATAGT TATAAAATAC AATTGCTCCT TAAAATATTG
AAGTCTATTT TTATTTTTCT GGAATATCAG
GCACACATCT ATGATCATGT TGATATAATG
AATGTGAAAT GCAGGGCCTT TCATATGCTA
NFKB
ATACATCAAA TTCAGGACTA CAAAGGAGCT
CCTGTTTAGA TTCTCGACTC TTTTCCCGAA
AGGACTGAAT GTCTCTGAGC TTTGGCATCG
818
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GTAACAGAAG AGGAGGGCGG
GGTCTGTGGC TACTTATTCC CATCATGTAC
TCATAACCAG CACAATTTTT TTTTTTAAGC
AGAACAGAGT GGCCAACTGT
AAGTGGGTAC CAGCTTTGAG
-480 TATCTCTCCC CACTCCCAGG GAGGAGGGAA CAGTCACATG TATTGAGAAT GAGTAAAGAT CGTGTCTAGT CCTAAGCACT
-400 GCACCATGTC TTCATGTCCC CTCTCATGGG ACACTGTGAT TACCACACTT TTGAATGAGG AGCTGAGATG TGAAGCGGCT
-320 GAAACCCCTT GCCCAGCCAC TCAAGCCCAG GCCACTCTTC AGCAACTCTT CCTGACAGCG CATCCCATCC CAAACACTCA
-240 ACTCAGAAGC AGGGAGCAGT CAGTTGGCCT GCTGGTCCAC ACCAGAGTC C CGCACCCCAA CTGCTGCTCT GCTTGGCAGA
CRE
-160 TGAGCCCTCG CCTTCACAGC TGACTTCCTG AAGGCTGTCA CAAGCCBGAT GAGGAGGTGA CAACAGGGTG GGTGCTGGTG
AP-2
￿
W
-80 GGAACCTGTG ACCACACTCT GGGGGCAGGG CAGGAAGTAG TAATGATATG ACGTTGGCCA GGGTGGGCCT GCCTGGGGAT
GC
￿
"TATA"
potA
pot A
Figure 7 .
￿
Nucleotide sequence of the first exon and 5' UTR flanking sequence, and part of the first intron of the mouse Pfp . The 79-bp region
constituting the first exon is boxed . -1 starts the 5' flanking sequence. +1 indicates the mRNA start site. Thepotential promoter and enhancer sequences
described in Results and Discussion are underlined . These sequence data have been submitted to the EMBL GenBank Data Library and have been
given the accession number X56613 .
GATCGCAGC ATTTTAAAAG CC CCATTGA CAACGCAGGT GTCCCCCTGG GCTTCAGTGG CGTCTTGGTG GGACTTCACI
gtaaggagga ggaagggtag gaagcaggga ggttgaggta ccctggggaa agagagttgg aaggtatagc caggaggaac
cagaaatgct agtagecagc cttcaagctc atccctcatt ccttcattgg gttggtgaca actcggggtt catgtgtcag
tgacatactg tccacagttt ccaagactat ttccagaagt tttggcagtt agagtttcgt taagaatgga aatgagccag
gtaaggagga tcatatttgc tatacctcag gcaacgggta aaccccatct cgasaggtgt aagggagggg aagggagggg
agaggaaggg agaggaagga aagggagggg agggaaaagg aggaagaatc gaagatctgg taaataaact cgtgacaatt
taagaatggc gagaagggac tgatgtcgat tgatcaaagt caccaatgtg ttggtctctt aagcaggttg agggaaaagg
ttgacaggat tctggggagc ttgtttatct cccagcctca cacatcacct ggaattc819
￿
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two protected fragments of 139 and 32 bases (data not shown).
This result again confirmed our observation that the 5' UTR
of PFP mRNA is spliced alternatively.
Potential Regulatory Elements in the 5' Flanking Region of
Mouse Pfp. The organization of the mouse Pfp gene and
the structures of the two mouse transcripts are summarized
schematically in Fig. 6. For comparison, the organization of
the human Pfp gene (15) is also shown in Fig. 6. Fig. 7 shows
the nucleotide sequence surrounding the first exon (first exon
sequence boxed as nucleotides +1 to +79) . In Fig. 7, we
also indicate potential promoter and enhancer elements and
unknown regulator motifs, which appear in both human and
mouse Pfp.
Two tandem "TATA" box-related elements (TAGTAA,
TGATAT) (24) couldbe identified at positions -43 and -32,
possibly directing transcription from the indicated position
+1 (Table 1 and Fig. 7) . The GC box, another upstream
promoter element (25), was found at positions -59 to -50.
Potential regulatory sequences and regions are given together with known elements. References are given after each element. See text for more
detailed discussion.
However, the mouse Pfp promoter lacked a typical CAAT
related element. Since we and others previously observed that
the mouse Pfp expression was modulated by various lym-
phokines and mitogens (7, 8, 12-14), the region of mouse
Pfp further upstream was inspected for other potential tran-
scriptional regulatory sequences by a homology comparison
to known regulatory elements and to human Pfp sequences.
Table 1 summarizes this type of analysis.
Discussion
A surprising finding in this study is that the mouse PFP
5' UTR consists of two types. The type 15' UTR consists
of 222 bp, whereas type II is 115 by long. Only the second
exon is affected by this difference: in types I and II, the second
exon contains 143 and 36 by of 5' UTR, respectively (see
schematic diagram in Fig. 6) . These two species appear to
be produced by the use of alternative acceptor splice sites.
Table 1. Potential Regulatory Sequences
Sequence
Appearing in the S' Flanking
Region
Region ofMouse Pfp
Elements
TGATAT -37 to -32 TATA-like (24)
TAGTAA -43 to -38
GGGGCAGGGC -59 to -50 GC box (25)
TGACAACA -103 to -96 UV responsive (27)
CCCCTGGCC -156 to -149 AP-2 binding (28)
CCGCACCCC -191 to -183
CCCCCACCC -696 to -688
AGCAGTc -226 to -220 CRE (29, 30, 31)
TGACTTCA -1077 to -1070
tCTGCCcATG -614 to -606 NIP binding (37)
TGAGTCAC -623 to -616 THE (32)
CCCAG-G-CAGAGTG -869 to -857 IFN-,y responsive (38)
AAAAAGCTGTTAAAAGTG -1023 to -1016 T cell-specific gene (40)
AGATAAAAATGGAAAATG -1263 to -1246
AGGGcCTTTCA -1138 to -1128 NFkB-like (41)
GGCCTG -15 to -10 Unknown, but appears in both human and mouse genes
-215 to -210
-756 to -751
GAGGGTGGG -22 to -14
-97 to -89
CCTGTGACCACA -76 to -65
AGCCGGATGAGG -117 to -107
ATGAGC -159 to -154
CAAGCCCAGGC -299 to -289
GGCTGAA -324 to -318
GAGGGAA -457 to -451
AGGCAGA -584 to -578
GGAAA -606 to -602For the production of type II, an internal acceptor splice site
in exon 2 was used. In this case, splicing resulted in the elimi-
nation of part of the second exon. Conversely, the mature
type I species might be viewed as incorporating an immedi-
atelyadjacent intron sequence into the mRNA. Thus,it seems
that these sequences can function either as an exon or as an
intron, illustrating the ambiguity of the terms "exon" and
"intron" The 107-bp region, which becomes a 3' end of the
first intron, contains a consensus lariat branch point sequence,
PyNPyTPuAPy (26). However, the intron sequence adjacent
to the 143 by of type 15' UTR does not contain the con-
sensus branch point sequence. Type I therefore may represent
a less favorable splicing product.
The first cis-acting element found upstream ofthe GC box
was a UV-responsive element to which an UV-induced pro-
tein binds (27). This element may affect the basal level of
Pfp expression considering its distance from the cap site (-103
to -96).
The mouse Pfp contained both activator protein 2 (AP-2)
binding sites (28) and CAMP-responsive elements (CRE)
V9-31). The AP-2 sequence responds both to 12-O-tetra-
decanoylphorbol-13-acetate (TPA) stimulation and cAMP (28).
As in many other genes in which more than one copy of
CRE-like and AP-2 sequences are present, mouse PFP con-
tains two CRE (-226 to -220, -1077 to -1070) and three
AP-2 binding sequences (-156 to -149, -191 to -183, -696
to -688). Ofthe two CRE, the proximal one (-226 to -220)
has only been found in a cfos gene (31) .
There is a perfect match of consensus TPA-responsive ele-
ments (TRE) (32) at positions -623 to -616. In this re-
gard, it should be noted that the TPA stimulates perforin
mRNA expression in T cells (10, 12). The activator protein
1 (AP-1), which binds to TRE, is the protooncogene cjun
protein, and its activity is modulated by the c-fosprotein (33).
The cfos gene itselfis induced with a variety of agents such
as serum, TPA, and epidermal growth factors (34, 35). Its
expression has also been associated with T cell activation and
proliferation (36). It is tempting to speculate that the pres-
ence of TRE in Pfp may indicate that the expression of Pfp
is regulated by a complex interaction ofseveral protooncogene
products. Adjacent to TRE, we found a transcriptional si-
lencer, a potential nuclear inhibitory protein (NIP)-binding
site (-614 to -606). The NIP-binding element was recently
identifiedin the human 11,3 gene (37). In addition, we found
a slight variation of IFN-y-responsive elements (38) at posi-
tion -869 to -857. This element couldexplain the elevation
of PFP activity after treatment of NK cellswith IFN-y (39).
Fujita et al. (40) described a purine-rich sequence that ap-
pears in T cell-specific genes such as 11,2, IFN-,y, IL-2R, and
HTLVIII genes (40). This sequence motif appears in some
cases as a pair. The mouse Pfp gene contains such a paired
element at positions -1023 to -1016 (proximal), and -1263
to -1246 (distal). Interestingly, in between these two potential
elements, CRE (-1077 to -1070) and a potential NFkB-
binding element (41) are found. This latter element is de-
tected in a variety of cellular genes involved in the immune
response. These genes include those encoding K light chain
Ig (41), MHC class I antigens (42), R2-microglobulin (43),
and IL-2 (44) . We also found three repeats of GGCCTG that
may represent a variation ofthe GCCCTG consensus sequence
described in the human Pfp (15). This latter sequence repeats
19 times in the human sequence.
As expected from the similarities between the mouse Pfp
and human Pfp in terms of genomic organization and ex-
pression properties, the putative transcription regulatory ele-
ments, described above for mouse Pfp, are found at similar
positions in the human gene. There are in fact stretches of
perfect matches in the 5' region of the mouse and human
Pfp. Two regions with a high degree ofhomology are found
within the first 650 bp. One is found immediately upstream
of the cap site (+1); an 80-bp stretch between positions -118
and -38 shows 87% sequence homology between human
and mouse Pfp. This region includes a GC-box, UVresponsive
elements, and two areas of perfect matches (-76 to -65 and
-117 to -107). The other region with a high level of ho-
mology appeared between nucleotides -623 and -578, which
shows an identity of almost 90% with a comparable region
of human Pfp. This region contains the TRE, NIP-binding
sequence, and a copy of the GGAAA motif (-606 to -602)
that was found in the IFN-inducible genes and humanIFN-ot
and -a genes (45) . One can further find the second AP-2
binding element, the first CRE, and four short stretches of
nucleotides that appear in both human and mouse Pfp in a
stretch between these two highly homologous regions. One
ofthe common motifs is a purine-rich sequence, a PU1 box-
like element (46) at nucleotide positions -457 to -451. The
PU.1 protein was shown to be a transcriptional activator that
is expressed in macrophages and B cells (46). Other putative
elements ofinterest, such as the third AP-2 binding element,
a repetitive GGCCTG (-756 to -751) motif, an IFN-y in-
duction element, the second CRE, NFkB-binding, and poten-
tial T cell gene-specific sequences are scattered further up-
stream beyond the first 650 bp.
Now that the genomic structure for mouse Pfp has been
determined, it will be important to determine the functions
of the putative enhancer- and promoter-like elements for this
important gene and to determine in turn the combined in-
fluence of transacting factors on these.
We thank Becki Robling, Dorothy Starnes, and Susan Fordyce for typing and editing the manuscript.
We also thank Dr. J. A. Trapani for initial collaborative assistance, Drs. Z. A. Cohn and R. M. Steinman
for continuous support and encouragement, Drs. Charles Wilde, Rick Bockrath, and Ann Roman for
critical review of the manuscript, and various members ofour lab for exchange of reagents and for critical
reading of this manuscript.
820
￿
Structure of the Mouse Pore-forming Protein GeneThis work was supported in part by U.S. Public Health Service (National Institutes of Health) grants
AI-28175, DK-20542, AR-40248, and CA-47307; andby grants from the American Cancer Society and
Irvington Institute for Medical Research. C.-C. Liu is a Fellow of the Irvington Institute for Medical
Research. J. D.-E Young is a Lucille P. Markey Scholar.
Address correspondence to Byoung S. Kwon, Department of Microbiology and Immunology, Walther
Oncology Center, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202.
Received for publication 14 September 1990 and in revised form 2 January 1991.
821
￿
Youn et al.
References
1. Henkart, P.A. 1985. Mechanism oflymphocyte-mediated cy- 16. Trapani, J.A., B.S. Kwon, C. Kozak, C. Chintamaneni, C.
totoxicity. Annu. Rev. Immunol. 3:31. Young, J.D.-E Young, and B. Dupont. 1990. Themouse per-
2. Podack, E.R. 1985 . The molecularmechanism oflymphocyte- forin gene intron-exon organization and location to chromo-
mediated tumor cell lysis. Immunol. Today. 6:21. some 10. J. Exp, Med. 71:545.
3. Young, J.D .-E, C.-C. Liu, P.M. Persechini, and Z.A. Cohn. 17. Young, J.D .-E, H. Hengartner, E.R.Podack, and Z.A. Cohn.
1988. Perforin-dependent and -independent pathways ofcyto- 1986 . Purification andcharacterization ofapore-forming pro-
toxicity mediated by lymphocytes. Immunol. Rev . 103:161. tein from granules of cloned lymphocytes with natural killer
4. Tschopp, J., and C.V.Jongeneel. 1988. Cytotoxic T lympho- activity. Cell. 44:849.
cyte mediated cytolysis. Biochemistry. 27:2641. 18 . Kwon, B.S., R. Halaban, G.S. Kim, L. Usack, S. Pomerantz,
5. Miiller-Eberhard, H.J. 1988. Themolecularbasisof target cell and A.K. Haq. 1987. A melanocyte-specific complementary
killingby humanlymphocytes andofkiller cell self-protection. DNA clonewhoseexpression is inducibleby melanotropin and
Immunol. Rev. 103:87. isobutylmethyl xanthine. Mol. Biol. Med. 4:339.
6. Shinkai, Y., K. Takio, andK. Okumura. 1988. Homology of 19. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA se-
perforin to theninthcomponent of complement (C9). Nature quencing with chain-terminating inhibitors. Proc. Natl. Acad.
(Lon4 334:525. Sci. USA. 74:5463.
7. Lichtenheld, M.G., K.J . Olsen, P. Lu, D.M. Lowrey, A. 20. Biggin, M., T Gibson, and G. Hung. 1983 . Buffer gradient
Hammed, H. Hengartener, andE.R. Podack. 1988. Structure gels and ['sS] label as an aid to rapid DNA sequence deter-
and function of human perforin. Nature (Loud). 158:1. mination. Proc. Nad. Acad. Sci. USA. 80:3963.
8. Kwon, B.S., M. Wakulchik, C.-C. Liu, P.M. Persechini, J.A. 21 . Messing, J., R. Crea, and P. H. Seeburg. 1981. A system for
Trapani, A.K. Haq, Y Kim, andJ.D.-E Young. 1989. The shotgun DNA sequencing. Nucleic Acids Res. 9:309.
structureof the mouselymphocyte pore-forming protein per- 22. Chen, EY, and P.H. Seeburg. 1985. Supercoil sequencing: a
forin. Biochem. Biophys. Res. Commun. 158:1. fast and simple method for sequencing plasmid DNA. DNA
9. Lowrey, D.M., T. Aebisher, K.J. Olsen, M.G. Lichetenheld, (NY). 4:165.
F. Rupp, H. Hengartner, and E.R. Podack. 1989. Cloningand 23 . Saiki, R.K., D.H. Gelfand, S. Stoffel, S.J.Scharf, R. Higuchi,
analysis and expression of murine perforin 1 cDNA, acompo- G.T. Horn, K.B. Mullis, and H.A. Erlich. 1988. Primer-directed
nent of cytolysic Tcell granules with homology to comple- enzymatic amplification of DNA with a thermostable DNA
ment component C9. Proc. Nad. Acad. Sci. USA. 86:247. polymerase. Science (Wash. DC). 239:487.
10. Liu, C.-C., S. Rafii, A. Granelli-Piperno, J.A. Trapani, and 24. Corden,J., B. Wasylyk, A. Buchwalder, P. Sassone-Corsi, C.
J.D.-E Young. 1989. Perforin andserine esterase gene expres- Kedinger, and P. Chambon. 1980. Promoter sequences of eu-
sion in stimulated human T cells. Kinetics, mitogen require- caryotic protein-coding genes. Science (Wash. DC). 209:1406.
ments, and effects of cyclosporin A. J. Exp. Med. 170:2105. 25 . Courey, A.J., and R. Tijian. 1988. Analysis of Spl in vivo re-
11 . Manyak, G.L., G.P. Norton, G.G. Lobe, R.C. Bleackley, H.K. veals multiple transcriptional domains, includinganovelgluta-
Gershenfeld, I.L. Weissman,V . Kumar, N.H. Sigal, andG.C. mine-rich activation motif. Cell. 55 :887.
Koo. 1989. 11,2 induces expression ofserine protease enzymes 26. Ruskin, B., A.R. Krainer, TManiatis, andM.R. Green. 1984.
and genes in natural killer and nonspecific Tkiller cells. J. Im- Excision of an intact intron as a novel lariat structure during
munol. 142:3703. pre-mRNA splicing in vitro. Cell. 38:317.
12. Liu, C.-C., S.V. Joag, B.S. Kwon, andJ.D.-E Young. 1990. 27. Ronai, Z., and I. Weinstein. 1990. Identification of UV in-
Inductionof perforin andserineesterase in amurine cytotoxic ducible protein which binds to aTGACAAC sequence on the
T lymphocyte clone. J. Immunol. 144:1196. polyoma virus regulatory region. Cancer Res. 50:5374.
13. Smyth, M.J., J.R. Ortaldo, Y Shinkai, H.Yagita, M. Nakata, 28. Imagawa, M., R. Chiu, and M. Karin. 1987. Transcription
K. Okumura, and H.A. Young. 1990.Interleukin2induction factor AP-2 mediates inductionby twodifferent signal-trans-
of pore-forming protein gene expression in human peripheral duction pathways: protein kinase C and cAMP. 1987. Cell.
blood CD8+ T cells. J. Exp. Med. 171:1269. 51:251.
14. Joag, S.V., C.-C. Liu, B.S. Kwon, WR. Clark, andJ.D .-E 29. Roesler, W.J., Vandenbark, G., and R. Hanson. 1988. Cyclic
Young. 1990. Expression of mRNAs for pore-forming pro- AMP and the induction of eukaryotic gene transcription. J.
tein and two serine esterases in murine primary and cloned Biol. Chem. 263:9063.
effector lymphocytes. J. Cell. Biochem. 43:1. 30. Short, J.M., A.Wynshaw-Boris, H.P. Short, and R.W. Hanson.
15. Lichtenheld, M.G., and E.R. Podack. 1989. Structure of the 1986. Characterization of the phosphoenolpyruvate carboxy-
human perforin gene.J. Immunol. 143:4267. kinase (GTP) promoter-regulatory region. J. Biol. Chem.261:9721.
31. Fisch, T M., R. Prywes,M.C. Simon, andR.G. Roeder. 1989.
Multiple sequence elements in thecfospromoter mediate in-
duction by cAMP. Genes & Dev. 3:198.
32. Lee, W, P. Mitchell, and R. Tijian. 1987. Purified transcrip-
tion factor AP-1 interacts with TPA-inducible enhancer ele-
ments. Cell. 49:741.
33. Nakabeppu, Y, K. Ryder, andD. Nathans. 1988.DNAbinding
activities of three murinejunproteins: stimulation by Fos. Cell.
55:907.
34. Treisman, R. 1985. Transient accumulation ofc-fos RNA fol-
lowing serum stimulation requires aconserved 5' elementand
c-fos 3' sequence. Cell. 42:889.
35. Treisman, R. 1986. Identification of aprotein-bindingsite that
mediates transcriptional response of the c-fos gene to serum
factor. Cell. 46:567.
36. Curran, T 1988.fos.In TheOncogene Handbook. E.P. Reddy,
A.M. Skalka,andTCurran,editors. Elsevier Science Publishers,
Amsterdam. 305-325.
37. Mathey-Prevot, B., N.C. Andrews, H.S. Murphy, S.G. Kreiss-
man, andD.G. Nathan. 1990. Positive and negative elements
regulate human interleukin 3 expression. Proc. Nad. Acad. Sci.
USA. 87:5046.
38. Boss, J.M., andJ. Strominger. 1986. Regulation of a trans-
fected human class II major histocompatibility complex gene
in human fibroblasts. Proc. Nad. Acad. Sci. USA. 83:9139.
39. Brunda, M.J., and V Davatelis. 1985. Augmentation of nat-
ural killer cell activity by recombinant interleukin-2andrecom-
822 Structure of the Mouse Pore-forming Protein Gene
binant interferons. In Mechanisms ofCytotoxicity by NK Cells.
R.B. HerbermanandD.M. Callewaert, editors. Academic Press,
Inc., Orlando. 397-407.
40. Fujita, T, H. Shibuya, T Ohashi, K. Yamanishi, and T
Taniguchi. 1986. Regulation ofhumaninterleukin-2 gene: func-
tional DNA sequences in the 5' flanking region for the gene
expression in activated T lymphocytes. Cell. 46:401.
41. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors in-
teract with theimmunoglobin enhancer sequences. Cell. 46:705.
42. Baldwin, A.S., andPA.Sharp. 1988. Two transcription factors,
Nf-kBand H2TF1, interact with a single regulatory sequence
in theclass I major histocompatibility complex promoter.Proc.
Natl. Acad. Sci. USA. 85:723.
43. Israel, A., A. Kimura, M. Kieran, O. Yano,J. Kanellopoulos,
O. Le Bail, andP. Kourilsky. 1987. A common positive trans-
acting factor binds to enhancer sequences in thepromoters of
mouse H-2 and 02-microglobulin genes. Proc Nad. Acad. Sci.
USA. 84:2653.
44. Hoyos, B., D.W. Ballard, E. Bohnlein, M. Siekevitz, and WC.
Greene. 1989. Kappa B- specific DNAbinding proteins: role
in the regulation of human interleukin-2 gene expression.
Science (Wash. DC). 244:457.
45. Porter, A.C.G., Y Chernajovsky, TC.Dale,C.S. Gilbert, G.R.
Starkland, and I.M. Kerr. 1988. Interferon response element
ofthehumangene 6-16. EMBO(Eur. Mol. Biol. Organ.)J. 7:85.
46. Klemsz, M.J., S.R. McKercher, A. Celada, C. Van Beveren,
and R.A. Maki. Themacrophage andB cell-specific transcrip-
tion factor PUl is related to the ets Onogene. Cell. 61:113.